Skip to main content
. 2020 Jan 20;21(2):676. doi: 10.3390/ijms21020676
MS Multiple sclerosis
IBD Inflammatory bowel disease
CD Crohn’s disease
Th17 Human T helper 17
CNS Central nervous system
IFN Interferon
EAE Experimental autoimmune encephalomyelitis
RRMS Remittent recurrent multiple sclerosis
HD Healthy donors
CIS Clinically isolated syndrome
mAb Monoclonal antibody
Tregs Anti-inflammatory regulatory T
S1PPBMCs Sphingosine-1 phosphate Peripheral blood mononuclear cells
GPR Global Pattern Recognition
FDR False discovery rate